AIM IMMUNOTECH INC. Liabilities Assumed
AIM IMMUNOTECH INC. (AIM) reported Liabilities Assumed of $672.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2016-03-29
- AIM IMMUNOTECH INC. liabilities assumed for fiscal 2015 was $672.00K, a 1038.98% increase from fiscal 2014.
- AIM IMMUNOTECH INC. liabilities assumed for fiscal 2014 was $59.00K, a 78.07% decline from fiscal 2013.
- AIM IMMUNOTECH INC. liabilities assumed for fiscal 2013 was $269.00K.
| Period end | Liabilities Assumed 12 month |
|---|---|
| 2015-12-31 | $672.00K 10-K · filed 2016-03-29 |
| 2014-12-31 | $59.00K 10-K · filed 2016-03-29 |
| 2013-12-31 | $269.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |